UCSF, Gladstone Launch Center for Neurovascular Brain Immunology
The new center will provide an integrated platform for basic and clinical research, bringing together vascular biology, immunology, and neuroscience.
University of California San Francisco
Give to UCSF
Displaying 1651 - 1680 of 16441
-
-
Can You Hug Your Grandkids After Receiving the COVID-19 Vaccine?
-
Minority Patients Miss Out On Life-Saving Cystic Fibrosis Drugs Due to Genetic Test Limitations
A new study shows how minority patients are effectively disqualified from receiving the latest cystic fibrosis drugs approved only for people with mutations more common among white patients.
-
COVID-19 Vaccines Are Likely Safe During Pregnancy. When Will We Know for Sure?
-
UCSF Partnership With San Francisco Brings COVID-19 Vaccinations to the Mission District
The vaccination site builds off previous work with Unidos en Salud to bring COVID-19 testing to the Mission District.
-
Could this Llama-Inspired Nanobody Help Curtail COVID?
A UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
-
‘This Is Fantastic’: Mass Vaccination Clinics to Play Key Role in Ending COVID-19 Pandemic
-
UCSF Expands Vaccination Effort in Partnership with City of San Francisco
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community
-
Alcohol and Your Heart: Just Getting a Buzz Can Trigger an Irregular Rhythm
-
COVID-19 Vaccine Fact Vs. Fiction: An Expert Weighs in on Common Fears
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.
-
Alcohol Causes Immediate Effects Linked to Heart Malady
UCSF researchers found that alcohol has an immediate effect on the heart in patients with atrial fibrillation, the most common life-threatening heart-rhythm disorder.
-
Study Finds Essential Workers Like Cooks Are More Likely to Die of COVID-19
-
Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.
-
UCSF Health Leader Mark Laret to Retire at Year’s End
A nationally recognized leader in health care, Laret joined UCSF in 2000.
-
Severe COVID-19 Disables Disease-Fighting Immune Circuit
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
-
The Inside Story of How the Bay Area Coronavirus Variant Was Discovered
-
Comprehensive Parnassus Heights Plan Moves Forward After UC Regents Vote
The Regents’ vote follows more than two years of robust community engagement spanning 28 public meetings to develop the CPHP, which reflects input from hundreds of stakeholders inside and outside UCSF.
-
UCSF Experts Among Highlights at 2021 Precision Medicine World Conference Focused on COVID-19
Scientific presentations will include advances in understanding the immune response, and precision medicine-driven development of new diagnostics, therapeutics, vaccines, and population health strategies.
-
COVID-19 Predictions for 2021 and Beyond
Few would have predicted last January that a pandemic would upend our daily lives. But one grueling year in, UCSF experts have a clearer view of the path ahead.
-
COVID-19 Variant First Found in Other Countries and States Now Seen More Frequently in California
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
-
Personalized Brain Stimulation Alleviates Severe Depression Symptoms
Depression is among the most common psychiatric disorders, affecting as many as 264 million people worldwide and leading to hundreds of thousands of deaths per year. But as many as 30 percent of patients do not respond to standard treatments such as medication or psychotherapy.
-
Community Workforce Agreement for Parnassus Project is Boon for Local Jobs, Economy
UCSF, the San Francisco Building and Construction Trades Council, and Herrero Boldt Webcor have announced a Community Workforce Agreement that will promote collaboration between the University, labor unions and construction firms during the construction of the new hospital at UCSF Helen Diller Medical Center at Parnassus Heights.
-
Is the COVID Vaccine Less Effective in Older Adults, and Should I Worry About Which One I Get?
-
Virus Versus Virus: ‘ReScan’ Antibody Test is a Powerful New Tool
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
-
How Worried Should You Be About the New Coronavirus Variant?
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
-
Career Office-Alum Collaboration Yields $2.3M Award
-
Brain Cells Most Vulnerable to Alzheimer’s Disease Identified by Scientists
A team of researchers has identified for the first time the neurons that are among the first victims of Alzheimer’s disease.
-
UCSF Administers Second Dose of COVID-19 Vaccine to Frontline Staff
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work.
-
Health Expert Proposes Distributing Vaccine by Lottery
-
How Fast Can Scientists Find the New Coronavirus Strains?